<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age/><report-id>US-RB-048726-13</report-id><gender>female</gender><reactions><reaction>Anxiety attack</reaction><reaction>Patient unable to sleep </reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Mucinex DM (Guaifenesin)</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>Mucinex DM (Dextromethorphan hydrobromide)</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>Xanax</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Product used for unknown indication</indication><indication>Anxiety disorder</indication></indications><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
  <ichicsrmessageheader>
    <messagetype>ICHICSR</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>1.0</messageformatrelease>
    <messagenumb>RB_00001AB9</messagenumb>
    <messagesenderidentifier>RECKITTBENCKISER</messagesenderidentifier>
    <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20130125145443</messagedate>
  </ichicsrmessageheader>
  <safetyreport>
    <safetyreportversion>1</safetyreportversion>
    <safetyreportid>US-RB-048726-13</safetyreportid>
    <primarysourcecountry>US</primarysourcecountry>
    <occurcountry>US</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>2013-01-25</transmissiondate>
    <reporttype>1</reporttype>
    <serious code="1">Yes</serious>
    <seriousnessdeath>2</seriousnessdeath>
    <seriousnesslifethreatening>2</seriousnesslifethreatening>
    <seriousnesshospitalization>2</seriousnesshospitalization>
    <seriousnessdisabling>2</seriousnessdisabling>
    <seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
    <seriousnessother>1</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>2013-01-14</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>2013-01-14</receiptdate>
    <additionaldocument>2</additionaldocument>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb>US-RB-048726-13</companynumb>
    <medicallyconfirm>2</medicallyconfirm>
    <primarysource>
      <reporterfamilyname>Privacy</reporterfamilyname>
      <reportercountry>US</reportercountry>
      <qualification code="5">Consumer or non-health professional</qualification>
    </primarysource>
    <sender>
      <sendertype>1</sendertype>
      <senderorganization>RECKITTBENCKISER</senderorganization>
      <senderdepartment>Global Pharmacovigilance Unit</senderdepartment>
      <sendertitle>Dr.</sendertitle>
      <sendergivename>Phil</sendergivename>
      <senderfamilyname>Berry</senderfamilyname>
      <senderstreetaddress>Dansom Lane</senderstreetaddress>
      <sendercity>Hull</sendercity>
      <senderpostcode>HU8 7DS</senderpostcode>
      <sendercountrycode>GB</sendercountrycode>
      <sendertel>1482 326</sendertel>
      <sendertelextension>151</sendertelextension>
      <sendertelcountrycode>44</sendertelcountrycode>
      <senderfax>1482 582</senderfax>
      <senderfaxextension>603</senderfaxextension>
      <senderfaxcountrycode>44</senderfaxcountrycode>
      <senderemailaddress>FDA@adr.ReckittBenckiser.com</senderemailaddress>
    </sender>
    <receiver>
      <receivertype>2</receivertype>
      <receiverorganization>RECKITTBENCKISER</receiverorganization>
      <receivercountrycode>US</receivercountrycode>
      <receiveremailaddress>esg@est.fda.gov</receiveremailaddress>
    </receiver>
    <patient>
      <patientinitial>R</patientinitial>
      <patientsex code="2">Female</patientsex>
      <patientmedicalhistorytext>The patient's present medical condition includes ANXIETY DISORDER [Anxiety disorder].</patientmedicalhistorytext>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>Anxiety disorder</patientepisodename>
        <patientmedicalcontinue>1</patientmedicalcontinue>
      </medicalhistoryepisode>
      <reaction>
        <primarysourcereaction>Anxiety attack</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>Anxiety attack</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>Anxiety</reactionmeddrapt>
        <reactionoutcome code="6">unknown</reactionoutcome>
      </reaction>
      <reaction>
        <primarysourcereaction>Patient unable to sleep </primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>Insomnia</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>Insomnia</reactionmeddrapt>
        <reactionoutcome code="6">unknown</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>Mucinex DM (Guaifenesin)</medicinalproduct>
        <drugbatchnumb>WO00509518</drugbatchnumb>
        <drugdosageform normalized="245">245</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>Product used for unknown indication</drugindication>
        <actiondrug code="5">Unknown</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>Guaifenesin</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Anxiety</drugreactionasses>
          <drugassessmentsource>Reckitt Benckiser</drugassessmentsource>
          <drugassessmentmethod>Algorithm</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Anxiety</drugreactionasses>
          <drugassessmentsource>Reporter</drugassessmentsource>
          <drugassessmentmethod>Global Introspection</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Insomnia</drugreactionasses>
          <drugassessmentsource>Reckitt Benckiser</drugassessmentsource>
          <drugassessmentmethod>Algorithm</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Insomnia</drugreactionasses>
          <drugassessmentsource>Reporter</drugassessmentsource>
          <drugassessmentmethod>Global Introspection</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>Mucinex DM (Dextromethorphan hydrobromide)</medicinalproduct>
        <actiondrug code="5">Unknown</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>Dextromethorphan hydrobromide</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Anxiety</drugreactionasses>
          <drugassessmentsource>Reckitt Benckiser</drugassessmentsource>
          <drugassessmentmethod>Algorithm</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Anxiety</drugreactionasses>
          <drugassessmentsource>Reporter</drugassessmentsource>
          <drugassessmentmethod>Global Introspection</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Insomnia</drugreactionasses>
          <drugassessmentsource>Reckitt Benckiser</drugassessmentsource>
          <drugassessmentmethod>Algorithm</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>Insomnia</drugreactionasses>
          <drugassessmentsource>Reporter</drugassessmentsource>
          <drugassessmentmethod>Global Introspection</drugassessmentmethod>
          <drugresult>Possible</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="2">concomitant</drugcharacterization>
        <medicinalproduct>Xanax</medicinalproduct>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>Anxiety disorder</drugindication>
        <actiondrug code="5">Unknown</actiondrug>
        <activesubstance>
          <activesubstancename>Alprazolam</activesubstancename>
        </activesubstance>
      </drug>
      <summary>
        <narrativeincludeclinical>Report No 1 received from <Semaphore x="2661215" class="Procedure" value="Ultrasonography" score="1.00" ID="C17230">US </Semaphore>Consumer Relations, Date 14-JAN 2013, Reference No: C342383770.Suspect <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">Drug</Semaphore>: <Semaphore x="887616" class="Medicine" value="Mucinex DM" score="0.93" ID="276343">Mucinex <Semaphore x="1863607" class="Disease or Finding" value="Double Outlet Right Ventricle" score="1.00" ID="C98916">DM </Semaphore></Semaphore>(<Semaphore x="648120" class="Medicine" value="guaiFENesin" score="0.74" ID="269877">Guaifenesin </Semaphore>; <Semaphore x="454266" class="Medicine" value="Dextromethorphan Hydrobromide" score="0.74" ID="187168">Dextromethorphan hydrobromide</Semaphore>).Dosing: Unknown.Case reference number <Semaphore x="2661215" class="Procedure" value="Ultrasonography" score="1.00" ID="C17230">US </Semaphore><Semaphore x="2467233" class="Disease or Finding" value="Retinoblastoma" score="1.00" ID="C7541">RB </Semaphore>048726-13 is a spontaneous case report sent by a consumer or <Semaphore x="2352630" class="Occupation" value="Other Health Care Professional" score="1.00" ID="C53289">other non health professional </Semaphore>which refers to a female aged Unknown.A female patient of an unknown aged took an unknown dose of the <Semaphore x="887616" class="Medicine" value="Mucinex DM" score="0.93" ID="276343">Mucinex <Semaphore x="1863607" class="Disease or Finding" value="Double Outlet Right Ventricle" score="1.00" ID="C98916">DM </Semaphore></Semaphore>and could not sleep and was anxious. Patient suffers from an <Semaphore x="1534652" class="Disease or Finding" value="Anxiety Disorder" score="1.00" ID="C2878">anxiety disorder </Semaphore>and she was taking <Semaphore x="1366502" class="Medicine" value="Xanax" score="0.87" ID="241256">Xanax </Semaphore>for it. She asked if the <Semaphore x="887616" class="Medicine" value="Mucinex DM" score="0.93" ID="276343">Mucinex <Semaphore x="1863607" class="Disease or Finding" value="Double Outlet Right Ventricle" score="1.00" ID="C98916">DM </Semaphore></Semaphore>could trigger the <Semaphore x="1855439" class="Disease or Finding" value="Disfigurement" score="1.00" ID="C50536">disorder</Semaphore>. Patient was also advised that the <Semaphore x="1863607" class="Disease or Finding" value="Double Outlet Right Ventricle" score="1.00" ID="C98916">DM </Semaphore>product should not be taken with any <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>that contains a MAOI inhibitor. She confirmed the <Semaphore x="1366502" class="Medicine" value="Xanax" score="0.87" ID="241256">Xanax </Semaphore>does not.Medical History: <Semaphore x="1534652" class="Disease or Finding" value="Anxiety Disorder" score="1.00" ID="C2878">Anxiety Disorder</Semaphore>.Concomitant <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">Drug</Semaphore>: <Semaphore x="1366502" class="Medicine" value="Xanax" score="0.87" ID="241256">Xanax</Semaphore>.The reaction was deemed serious by the reporter because it was classed as medically significant due to <Semaphore x="2753054" class="MedDRA LLT" value="Anxiety" score="1.00" ID="10002855"><Semaphore x="1534652" class="Disease or Finding" value="Anxiety Disorder" score="1.00" ID="C2878">Anxiety </Semaphore>Attack</Semaphore>.The reporter's causality for the case was Possible. The reporting consumer or <Semaphore x="2352630" class="Occupation" value="Other Health Care Professional" score="1.00" ID="C53289">other non health professional</Semaphore>'s clinical <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>for <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore><Semaphore x="887616" class="Medicine" value="Mucinex DM" score="0.93" ID="276343">MUCINEX <Semaphore x="1863607" class="Disease or Finding" value="Double Outlet Right Ventricle" score="1.00" ID="C98916">DM </Semaphore></Semaphore>[<Semaphore x="648120" class="Medicine" value="guaiFENesin" score="0.74" ID="269877">Guaifenesin</Semaphore>; <Semaphore x="454266" class="Medicine" value="Dextromethorphan Hydrobromide" score="0.74" ID="187168">Dextromethorphan hydrobromide</Semaphore>] is as follows: serious; with a relatedness of Possible.The company's <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>for the case was possible and unlisted.No further information was available at the time of report.Case <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">Outcome</Semaphore>: Unknown.</narrativeincludeclinical>
        <reportercomment>Reporter Causality: Possible</reportercomment>
        <senderdiagnosismeddraversion>15.1</senderdiagnosismeddraversion>
        <senderdiagnosis>Anxiety</senderdiagnosis>
      </summary>
    </patient>
    <!--12129197::0::FDA-AS2-PRD-->
  </safetyreport>
</ichicsr></original></faers>